Stoke Therapeutics, Inc.
Institutional Ownership & Holdings Analysis
About
stoke-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | Skorpios Trust(2025-03-31) | $45.9M |
2 | BlackRock, Inc.(2025-03-31) | $39.0M |
3 | Lynx1 Capital Management LP(2025-03-31) | $35.2M |
4 | RTW INVESTMENTS, LP(2025-03-31) | $34.1M |
5 | BAKER BROS. ADVISORS LP(2025-03-31) | $30.8M |
6 | Redmile Group, LLC(2025-03-31) | $29.8M |
7 | MORGAN STANLEY(2025-03-31) | $23.8M |
8 | TORONTO DOMINION BANK(2025-03-31) | $21.1M |
9 | VANGUARD GROUP INC(2025-03-31) | $18.5M |
10 | FMR LLC(2025-03-31) | $16.9M |
11 | Siren, L.L.C.(2025-03-31) | $14.9M |
12 | GOLDMAN SACHS GROUP INC(2025-03-31) | $11.1M |
13 | STATE STREET CORP(2025-03-31) | $10.5M |
14 | Assenagon Asset Management S.A.(2025-03-31) | $6.4M |
15 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $6.0M |
16 | Checkpoint Capital L.P.(2025-03-31) | $4.9M |
17 | MPM BioImpact LLC(2025-03-31) | $4.6M |
18 | DIMENSIONAL FUND ADVISORS LP(2025-03-31) | $4.4M |
19 | Granahan Investment Management, LLC(2025-03-31) | $4.4M |
20 | BANK OF AMERICA CORP /DE/(2025-03-31) | $3.5M |
As of 2025-03-31
Value:$45.9M
As of 2025-03-31
Value:$39.0M
As of 2025-03-31
Value:$35.2M
As of 2025-03-31
Value:$34.1M
As of 2025-03-31
Value:$30.8M
As of 2025-03-31
Value:$29.8M
As of 2025-03-31
Value:$23.8M
As of 2025-03-31
Value:$21.1M
As of 2025-03-31
Value:$18.5M
#10FMR LLC
As of 2025-03-31
Value:$16.9M
As of 2025-03-31
Value:$14.9M
As of 2025-03-31
Value:$11.1M
As of 2025-03-31
Value:$10.5M
As of 2025-03-31
Value:$6.4M
As of 2025-03-31
Value:$6.0M
As of 2025-03-31
Value:$4.9M
As of 2025-03-31
Value:$4.6M
As of 2025-03-31
Value:$4.4M
As of 2025-03-31
Value:$4.4M
As of 2025-03-31
Value:$3.5M
Total Institutional Holders:156
Top 10 Holders Own:70.1%